September 1, 2021
Brave New Meat podcast host Doug Grant talks with Michael Aucoin, CEO of investment firm Eat Beyond Global Holdings. As a publicly traded stock on the Canadian Securities Exchange, Eat Beyond (CSE: EATS) is currently one of the only options available offering retail investors early exposure to emerging protein tech startups.
July 6, 2021
Rarely do retail investors have the opportunity to gain exposure and access to a new technology this early. That’s partly because Agronomics — which bills itself as “a thematic investment play into the clean meat sector” — is one of the only publicly traded options available to those who see the potential in cell-cultured meat.
February 24, 2021
Over the next two years, many cultured meat startups will bring products to market leading to acquisitions and IPOs as the industry matures. Looking toward this future, it’s worth considering how valuable these companies could be.
February 1, 2021
Investor and author Jim Mellon talks one-on-one with Doug Grant, host of the Brave New Meat podcast, to discuss his new book, Moo’s Law, and the investment opportunity in cultivated meat.
January 12, 2021
What I’ve learned through my first eleven Brave New Meat podcast interviews with founders and investors in the cultured meat industry
December 29, 2020
Cultivated ground meat has the potential to unravel the business model of the beef industry.
We use cookies for core site functionality and optional features, such as embedded media. Choose whether to allow all cookies or keep strictly necessary only.